NCT03882983View on ClinicalTrials.gov

Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Chronic Wounds
Interventions
DRUG

Antria Cell Preparation Process

"Biological/Vaccine: Stromal Vascular Fraction The SVF obtained from adipose tissue will be added to the graft~Other Names:~* Stromal Vascular Fraction~* Adiployx Biological/Vaccine:"

Trial Locations (1)

15701

RECRUITING

Indiana Regional Medical Center, Indiana

Sponsors

Lead Sponsor

Antria
All Listed Sponsors
lead

Antria

INDUSTRY

NCT03882983 - Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound | Biotech Hunter | Biotech Hunter